Krupa K. Savalia, M.D., Ph.D.
Assistant Professor, Department of Neurological Surgery and Neurology
To see if Krupa K. Savalia is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
UC Davis Medical Center
UC Davis Medical Center
2315 Stockton Blvd.
Sacramento, CA 95817
Phone: 800-2-UCDAVIS (800-282-3284)
Additional Numbers
Physician Referrals
Philosophy of Care
My patients often present to the intensive care unit with an unexpected and potentially devastating neurologic injury. As such, it is a privilege for me to utilize my expertise as a neurointensivist to prioritize providing personalized, evidence-based care. I strive to work with various subspecialists in a highly communicative and collaborative manner to achieve this goal in alignment with the patient's own values. It is additionally important for me to inform, educate and guide patients, family members, and/or their surrogate decision makers as they face the tremendous uncertainty and fear that often accompanies neurologic injuries.
Clinical Interests
Dr. Savalia is a neurologist with subspecialty expertise in neurocritical care. As a neurointensivist, Dr. Savalia takes care of patients with acute, life-threatening neurological and neurosurgical conditions such as traumatic brain injury, acute ischemic or hemorrhagic stroke, spinal cord injury, intra/extra-axial hemorrhage, status epilepticus, neuromuscular emergencies and post-cardiac arrest neurologic care.
She has additional expertise in the utilization of multimodal neuromonitoring which includes monitoring intracranial pressure, brain tissue oxygenation, and cerebral microdialysis. Dr. Savalia™s clinical interests include utilization of novel medical technologies (e.g., multimodal neuromonitoring and continuous electroencephalography) to provide personalized care with the goal of mitigating further neurologic injury and optimizing neurologic recovery.
Research/Academic Interests
Dr. Savalia is actively involved in developing a research program that focuses on the development of nanotherapeutics for combating traumatic brain injury. She is specifically interested in the time-dependent changes in blood-brain-barrier disruption and harnessing that knowledge to develop and deliver novel therapies to the brain. Dr. Savalia is also actively involved in educating and training medical students, residents, and fellows when they rotate with the neurocritical care service.
Division
Neurological Surgery
Neurology
Undergraduate School
B.S., Biomedical Engineering, University of Southern California, Los Angeles CA
Medical School
M.D., University of Nebraska College of Medicine, Omaha NE
Other School
Ph.D., Cellular & Integrative Physiology, University of Nebraska, Omaha NE
Internship
Internal Medicine, Georgetown University, Washington DC
Residency
Internal Medicine, Georgetown University, Washington DC
Fellowship
Neurocritical Care, University of Pennsylvania, Philadelphia PA
Distinguished Poster & Travel Grant Award, Neurocritical Care Society, 2021
Spirit Award, patient-nominated, Georgetown University, 2017, 2018
Presidential Leadership Summit Travel Award to The White House, National Campus Leadership Council, 2015
10th Annual Meeting Travel Award, American Physician Scientists Association, 2015
Dr. Jane Reckelhoff Award for Best Oral Presentation, Trainee Symposium Competition, International Society of Hypertension, 2013
Sharma A, Savalia K, Parekh SG. Inflammatory Aseptic Arthropathy in the Setting of COVID-19: A Case Report. J Orthopaedic Case Rep. 2022 Feb;12(2).
Savalia K, Sekar P, Moomaw CJ, Koch S, Sheth KN, Woo D, Mayson D; ERICH Investigators. Effect of Primary Prophylactic Antiseizure Medication for Seizure Prevention Following Intracerebral Hemorrhage in the ERICH Study. J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106143. doi:10.1016/j.jstrokecerebrovasdis.2021.106143. Epub 2021 Oct 26. PMID:34715523.
Savalia K, Manickam DS, Rosenbaugh EG, Tian J, Ahmad IM, Kabanov AV, Zimmerman MC. Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration. Free Radic Biol Med. 2014 Aug;73:299-307. doi:10.1016/j.freeradbiomed.2014.06.001. Epub 2014 Jun 9. PMID:24924945.
Rosenbaugh EG, Savalia KK, Manickam DS, Zimmerman MC. Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases. Am J Physiol Regul Integr Comp Physiol. 2013 Jun 1;304(11):R917-28. doi:10.1152/ajpregu.00395.2012. Epub 2013 Apr 3. PMID:23552499.
Nolan KJ, Savalia KK, Yarossi M, Elovic EP. Evaluation of a dynamic ankle foot orthosis in hemiplegic gait: A case report. NeuroRehabilitation. 2010;27(4):343-50. doi:10.3233/NRE-2010-0618. PMID:21160124.
Nolan KJ, Savalia KK, Lequerica AH, Elovic EP. Objective assessment of functional ambulation in adults with hemiplegia using ankle foot orthotics after stroke. PM R. 2009 Jun;1(6):524-9. doi:10.1016/j.pmrj.2009.04.011. PMID:19627941.
Savalia K, Kalanuria A, Kofke A. Part 5: Neurological Applications of Hemodynamics and Pulmonary Monitoring. Layon AJ, Gabrielli A, LeRoux P, O'Phelan KH, Gabrielli EM, Levine J, Kumar MA (Eds). Textbook of Neurointensive Care, 3rd Edition, Springer Publishing. (In Progress)